- Home
- KZIA vs RKDA Comparison
KZIA vs RKDA Comparison
Compare KZIA & RKDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- RKDA
- Stock Information
- Founded
- KZIA 1994
- RKDA 2002
- Country
- KZIA Australia
- RKDA United States
- Employees
- KZIA N/A
- RKDA N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- RKDA Agricultural Chemicals
- Sector
- KZIA Health Care
- RKDA Industrials
- Exchange
- KZIA Nasdaq
- RKDA Nasdaq
- Market Cap
- KZIA 6.0M
- RKDA 6.6M
- IPO Year
- KZIA 1999
- RKDA 2015
- Fundamental
- Price
- KZIA $0.88
- RKDA $3.98
- Analyst Decision
- KZIA Strong Buy
- RKDA Strong Buy
- Analyst Count
- KZIA 2
- RKDA 1
- Target Price
- KZIA $11.50
- RKDA $6.00
- AVG Volume (30 Days)
- KZIA 5.5M
- RKDA 6.2K
- Earning Date
- KZIA 03-26-2025
- RKDA 03-27-2025
- Dividend Yield
- KZIA N/A
- RKDA N/A
- EPS Growth
- KZIA N/A
- RKDA N/A
- EPS
- KZIA N/A
- RKDA N/A
- Revenue
- KZIA $1,655,324.00
- RKDA $5,482,000.00
- Revenue This Year
- KZIA N/A
- RKDA N/A
- Revenue Next Year
- KZIA N/A
- RKDA $30.00
- P/E Ratio
- KZIA N/A
- RKDA N/A
- Revenue Growth
- KZIA 248000.00
- RKDA 24.00
- 52 Week Low
- KZIA $0.85
- RKDA $1.85
- 52 Week High
- KZIA $15.80
- RKDA $10.31
- Technical
- Relative Strength Index (RSI)
- KZIA 29.00
- RKDA 25.98
- Support Level
- KZIA $0.90
- RKDA $4.74
- Resistance Level
- KZIA $1.60
- RKDA $4.85
- Average True Range (ATR)
- KZIA 0.14
- RKDA 0.20
- MACD
- KZIA 0.02
- RKDA -0.07
- Stochastic Oscillator
- KZIA 4.00
- RKDA 13.61
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
About RKDA Arcadia Biosciences Inc.
Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water and others.